Back to 2006, Terhi Jokilehto and Krista Rantanen reported that the expression of EGLN1 increased in the less differentiated phenotype, partially relocating from cytoplasm to nucleus in HNSCC. Here, EGLN1 is linked to head and neck squamous cell carcinoma.